Repligen Corporation

(RGEN) Trade

By |

Profile

Repligen Corp is a bioprocessing company that develops, produces and commercializes innovative biologic drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in the United States.

Contact Information

Website: www.repligen.com
Email: investors@repligen.com
Main Phone: +1 781 250-0111
Address: 41 Seyon Street, Building 1
Address 2: Suite 100
State: MA
City / Town: Waltham
Country: USA
Postal Code: 02453

Issuer Information

Exchange: NGS
CEO: Tony J. Hunt
Employees: 548
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)


Gathering Data... Please wait

Profile

Repligen Corp is a bioprocessing company that develops, produces and commercializes innovative biologic drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in the United States.

Contact Information

Website: www.repligen.com
Email: investors@repligen.com
Main Phone: +1 781 250-0111
Address: 41 Seyon Street, Building 1
Address 2: Suite 100
State: MA
City / Town: Waltham
Country: USA
Postal Code: 02453

Issuer Information

Exchange: NGS
CEO: Tony J. Hunt
Employees: 548
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 79.74 $ 0.73 (0.92%)
Last Price 79.74 Change $ 0.73 Change % 0.92 Tick N/A
Bid 78.01 Bid Size 200.00 Ask 82.64 Ask Size 100.00
Open 79.34 High 80.97 Low 78.01 Prev Close 79.01
Last Trade Volume 497,598 52 Wk Hi 99.25 52 Wk Low 48.26
Market Cap 4.1 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 51,530,792.00 EPS (TTM) 0.57 PE Ratio 139.90 Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 20 36
Number of Buys 9 17
Number of Sells 11 19
Net Activity -248955 -1452880
Last 10 Buys Shares
Karen A. Dawes 1,000
Glenn L. Cooper 1,000
Glenn L. Cooper 1,000
Glenn L. Cooper 1,000
Michael A. Griffith 1,000
Michael A. Griffith 1,000
Michael A. Griffith 1,000
Karen A. Dawes 1,000
Alfred L. Goldberg 1,000
Earl W. Henry 1,000
Last 10 Sell Shares
Thomas F. Ryan 1,000
Tony J. Hunt 1,000
Roy T. Eddleman 1,000
Karen A. Dawes 1,000
Roy T. Eddleman 1,000
Roy T. Eddleman 1,000
Nicolas M. Barthelemy 1,000
Roy T. Eddleman 1,000
Roy T. Eddleman 1,000
Thomas F. Ryan 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 50 50 50 50
Low Target Price Estimate 40 40 40 40
Mean Target Price Estimate 46.29 46.29 46.29 46.29
Standard Deviation 3.45 3.45 3.45 3.45
Date of Most Recent Estimate 06/04/18 05/09/18 05/09/18 06/04/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 6 6 6 6
Moderate Buy 1 1 1 1
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.38 1.38 1.38 1.38